Showing results (11-20 of 288) with videos related to
Sort By:
Pageof 29
Antimicrobial Agents and Chemotherapy|August 22, 2000
Characterization of a variant of vga(A) conferring resistance to streptogramin A and related compoundsJ Haroche, J Allignet, C Buchrieser, et al.La Revue De Medecine Interne|March 21, 2009
[Takayasu arteritis: a French single centre experience]L Arnaud, J Haroche, J-C Piette, et al.Autoimmunity Reviews|August 23, 2011
Pathogenesis of Takayasu's arteritis: a 2011 updateLaurent Arnaud, Julien Haroche, Alexis Mathian, et al.Autoimmunity Reviews|September 21, 2013
Pathogenesis of relapsing polychondritis: a 2013 updateLaurent Arnaud, Alexis Mathian, Julien Haroche, et al.British Journal of Haematology|November 13, 2024
Methotrexate and cytarabine in adult LCH: High risk, high reward and maintenance free?Jithma P Abeykoon, Ronald S Go, Levi-Dan Azoulay, et al.La Revue De Medecine Interne|September 23, 2008
[Pathogenesis of primary large vessel arteritis]L Arnaud, J Haroche, P Duhaut, et al.Journal of Neuroradiology = Journal De Neuroradiologie|October 19, 2010
[Central nervous system involvement in systemic diseases: Spectrum of MRI findings]A Drier, F Bonneville, J Haroche, et al.Leukemia|June 28, 2020
Erdheim-Chester disease: a rapidly evolving disease modelFrancesco Pegoraro, Matthias Papo, Valerio Maniscalco, et al.Travel Medicine and Infectious Disease|November 12, 2025
Rhino-orbital conidiobolomycosis in non-endemic Settings. A diagnostic and therapeutic challengeRomain Gueneau, Lei Tanaka, Pierre Reimbold, et al.Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 23, 2020
Factors associated with implantable cardioverter defibrillators appropriate therapy in cardiac sarcoidosis: a meta-analysisLevi-Dan Azoulay, Xavier Waintraub, Julien Haroche, et al.Pageof 29